Study Of Pulmonary Function Research Articles

Effects on Lung Function of Multiple Expansion Thoracoplasty in Children With Thoracic Insufficiency Syndrome: A Longitudinal Study

Longitudinal study of intraoperative pulmonary function in young children with thoracic hypoplasia and scoliosis undergoing multiple expansion thoracoplasty using the vertical expandable prosthetic titanium ribs (VEPTRs). To test the long-term efficacy of VEPTR multiple expansion thoracoplasty. To our knowledge, no direct measurements of pulmonary function have been reported with VEPTR expansion thoracoplasty. There were 10 children with thoracic insufficiency syndrome, secondary to thoracic hypoplasia with progressive scoliosis, studied. A mobile pulmonary function laboratory unit was used to study forced vital capacity (FVC), maximum expiratory flow volume curves, and respiratory system compliance (Crs) with the patient under general anesthesia immediately before and after expansion thoracoplasty. Studies were repeated every 6 months at each subsequent operation for expansion thoracoplasty for the duration up to 33 months. At the baseline studies, FVC showed a moderate-to-severe decrease (69% of predicted values), indicating the presence of significant restrictive lung defect. Only 1 of 10 children had severe airway obstruction. The baseline Crs was markedly decreased in part because of the presence of significant atelectasis. Crs increased with an average of 42% after repeated hyperinflation (deep sighs). There was no change in lung volume or function immediately before versus after completion of expansion thoracoplasty. FVC increased significantly over time, with an average rate of 26.8% per year, the rate of increase similar to that of healthy children of comparative ages. In terms of percent-predicted values, FVC did not change significantly between the baseline and last test, indicating that in most children studied, lung growth kept up with body growth. Although it is difficult to assess the extent of the efficacy without a proper or historical control group for comparison, the present study indicates that in children with severe thoracic insufficiency syndrome, the insertion of VEPTRs with multiple expansion thoracoplasties is beneficial over time, by allowing the lungs to expand with body growth without further deterioration in lung function.

Reference Values for Pulmonary Function in Asian Indians Living in the United States

To establish reference values for pulmonary function in the Asian-Indian population living in the United States. Five-year cross-sectional study of pulmonary function in healthy adult Asian Indians living in the United States, using American Thoracic Society guidelines for measuring pulmonary function. Measurement of pulmonary function in healthy nonsmoking Asian Indians in a pulmonary function laboratory or at festivals, picnics, and ceremonies where subjects could be conveniently recruited. Four hundred sixty subjects from a population of Asian Indians residing in the Chicago metropolitan area. Spirometry was performed in all subjects with measurements of FEV(1), FVC, and forced expiratory flow between 25% and 75% of vital capacity (FEF(25-75)). Lung volumes were measured in eighty subjects. Prediction equations for FEV(1), FVC, and FEF(25-75) were derived using multiple regression analysis. Three hundred sixty-three subjects (226 men and 137 women) met the inclusion criteria. Spirometric values derived from our prediction equations, when compared to the values for whites from the selected studies in the literature, showed FVC to be 20 to 24% lower in men and 25 to 28% lower in women. FEV(1) was 16 to 23% lower in men and 20 to 26% lower in women. Differences were not quite as large when compared to values from African Americans and other studies on Asians. We provide reference values for pulmonary function in nonsmoking Asian Indians living in the United States. These reference values should be used for evaluation of pulmonary function in this population.

A 10‐year follow‐up study of pulmonary function in symptomatic elite cross‐country skiers – athletes and bronchial dysfunctions

A high prevalence of asthma-like symptoms and abnormal bronchial reactivity to various stimuli has been reported among endurance athletes. This report presents the cases of three cross-country skiers who have shown a progressive development of airway obstruction during their sport careers. The observed decline in FEV1, FEV1/FVC and/or FVC (FEV, forced expiratory volume; FVC, forced expiratory vital capacity) was greater than expected from longitudinal regression equations describing the ageing effect on pulmonary function. The three subjects encountered abnormal respiratory discomfort during their sport activity which was not systematically associated with abnormal bronchial reactivity (either to methacholine or exercise hyperventilation). At the end of the follow-up periods (9-12 years), all three skiers presented objective signs of airflow limitations during intense exercise. This report suggests that repeated chronic hyperventilation of cold dry air in cross-country skiers for several years can induce permanent bronchial disorders which may include remodeling processes and induce ventilatory limitations during intense exercise.

Lung function in children with diabetes mellitus.

A cross-sectional study design was undertaken to assess pulmonary function in children with insulin-dependent diabetes mellitus (IDDM), and to establish if there is any relationship with diabetic factors and complications. Thirty-eight children (10 +/- 1.8 years) with IDDM and without clinical or radiological evidence of lung involvement, and 41 healthy age-matched reference subjects, underwent a pulmonary function study. Thirteen (34%) of 38 subjects with IDDM were studied at the onset of their disease. Adjusted values expressed as SD score of forced vital capacity (FVC), forced expiratory volume in 1 sec (FEV(1)), and the transfer factor for carbon monoxide (TLCO) were found to be significantly lower than in controls (-0.54 +/- 0.87 vs. 0.40 +/- 1.10, P = 0.0008; -0.11 +/- 0.96 vs. 0.52 +/- 1.07, P = 0.01; -1.60 +/- 1.07 vs. -0.57 +/- 1.28, P = 0.001, respectively). These differences also existed in the group investigated at onset of diabetes. Residual volume (RV) and RV/total lung capacity ratio (RV/TLC) were significantly higher in the whole group of patients with IDDM than in controls (-0.20 +/- 0.83 vs. -0.80 +/- 0.88, P = 0.003; and 26 +/- 6.2 vs. 21 +/- 5.0, P = 0.0002, respectively). Seventeen patients (45%) had abnormal pulmonary function (SD score, less than -1.64): 16 subjects had reduced TLCO, 4 had reduced FVC, and in 3 of the 17, both functional indices were abnormal. There was no significant relationship between pulmonary function indices and diabetic factors or complications. The only significant association was between abnormal TLCO and females (P = 0.03), suggesting that sex may be a predisposing factor for the development of pulmonary complications. This study supports the view that the lung is functionally involved in children with IDDM early on in the course of the disease.

A Longitudinal Study of Lung Function in Nonsmoking Patients With Rheumatoid Arthritis

s: Patients with rheumatoid arthritis (RA) have a high prevalence of pulmonary function test (PFT) abnormality, but the long-term significance of this is unknown. We performed a longitudinal study of pulmonary function in asymptomatic, nonsmoking patients with active RA requiring disease-modifying drugs. We looked for temporal change in lung function and characteristics that would predict subsequent development of PFT abnormality or respiratory symptoms. In 1990, 52 patients (44 women; age range, 29 to 78 years; median, 56 years) underwent clinical assessment (drug history, RA severity, immunologic, and inflammatory markers) and PFTs (spirometry, body plethysmography, gas transfer). PFT results were expressed as standardized residuals (SRs). Thirty-eight patients were reassessed in 2000. A self-administered questionnaire was used to identify respiratory symptoms. The prevalence of pulmonary function abnormality was higher than expected compared with a reference population, but there was no significant increase in number over 10 years (8.7% in 1990 and 8.8% in 2000). When assessed by group means and compared with reference values, reduced diffusing capacity of the lung for carbon monoxide (DLCO) and increased ratio of residual volume (RV) to total lung capacity (TLC) [RV/TLC] were the only abnormalities to develop over the study period (mean DLCO in 2000, - 0.47 SR; 95% confidence interval [CI], - 0.91 to - 0.01; RV/TLC, 0.49 SR; 95% CI, 0.13 to 0.84). However, rates of change of pulmonary function variables were not significantly different from zero. Logistic regression did not identify any meaningful relationship between disease characteristics and PFT abnormality. Asymptomatic patients with RA have a higher prevalence of PFT abnormality than expected, but these do not increase in number over time. We did not identify any patient or disease-specific characteristic that could predict the development of respiratory disease in patients with RA. Analysis using percentage of predicted values, rather than SRs, is misleading as it exaggerates the extent of abnormality present. Abnormal lung function is a common and probably benign finding in nonsmoking, asymptomatic patients with RA.

Flow limitation in infants with bronchopulmonary dysplasia and respiratory function at school age

Bronchopulmonary dysplasia is associated with abnormalities in lung function during infancy, yet many infants recover with no respiratory problems in the long term. We therefore did a longitudinal study of pulmonary function in 18 children with moderate to severe bronchopulmonary dysplasia. Forced expiratory volume in 1 s (FEV1) and forced mid-expiratory flow (FEF25-75) at school age were lower than normal in 15 of 18 children, and both showed a significant positive correlation with the maximal flow at functional residual capacity (Vmax(FRC)) at 24 months of age (r=0.68 and 0.85, respectively). Our results suggest that assessment of respiratory function during infancy can help to identify children with bronchopulmonary dysplasia at risk of incomplete recovery of respiratory function during childhood.

Detección de estenosis de vena cava superior con cortocircuito vena cava superior-arteria pulmonar superior izquierda e hipertensión pulmonar mediante estudios de medicina nuclear

We present a 59 year old patient diagnosed of right superior lobe pulmonary carcinoma by CT scan. A ventilation/perfusion pulmonary scintigraphy quantified for study of pulmonary function after surgery was performed. The images show an abnormal pattern of the distribution of macroaggregate albumin (MAA) and extrapulmonary presence of tracer (right/left shunt). A first step dynamic study showed the existence of superior cava stenosis and passage of the tracer from the vena cava to the left pulmonary artery by collateral circulation (innominate vein) that not only explained the existence of the abnormal pattern of the MAA distribution but also what the cause of the right/left shunt was. After the resolution of the stenosis, the distribution pattern became normal and the extrapulmonary presence of MAA disappeared.

Pulmonary function study of myasthenia‐gravis patients treated with double‐filtration plasmapheresis

The aim of this study was to investigate the changes in pulmonary function tests for patients with myasthenia gravis (MG) after treatment with double filtration plasmapheresis (DFP) and to evaluate whether pulmonary function tests predict the efficacy of DFP treatment. Thirty-five MG patients (20 females and 15 males, age range 21-69 years) underwent DFP for between four and eight consecutive sessions. Vital capacity (VC), maximal inspiratory pressure (Pi(max)), and MG score were measured before and after DFP. Based on the results of pulmonary function tests, the patients were divided into dyspnea (VC < 1.0 L or Pi(max) < -25 cm H(2)O) and control groups (VC > 1.0 L and Pi(max) > -25 cm H(2)O). The dyspnea group had a significantly better response to DFP treatment, reflected in the decrease of the MG-score (P=0.0327), and the increase in VC value (P=0.0561). Higher clearance rates of acetylcholine receptor antibody (AchRAb) had a trend toward higher changes of VC. In conclusion, VC might better serve as a predictor for the effect of DFP in the dyspnea patient group because of better correlation with clinical improvement and AchRAb clearance.

Breathing easy: a prospective study of optimism and pulmonary function in the normative aging study.

Although there is good evidence that emotions are associated with chronic airways obstruction, evidence for the influence of psychological factors on the level and decline of pulmonary function is sparse. Optimism has been linked to enhanced well-being, whereas pessimism has been identified as a risk factor for poor physical health. This investigation examines prospectively the effects of optimism versus pessimism on pulmonary function. Data are from the Veterans Administration Normative Aging Study, an ongoing cohort of older men. In 1986, 670 men completed the revised Minnesota Multiphasic Personality Inventory from which we derived the bipolar Revised Optimism-Pessimism Scale. During an average of 8 years of follow-up, an average of 3 pulmonary function exams were obtained. Men with a more optimistic explanatory style had significantly higher levels of forced expiratory volume in 1 sec (FEV1) and forced vital capacity (both p < .01). Interactions between time and optimism suggested that rate of decline in FEV1 over time was slower in men with a more optimistic explanatory style relative to men who were more pessimistic. These data are the first to link optimism with higher levels of pulmonary function and slower rate of pulmonary function decline in older men, a protective effect that is independent of smoking.

A prospective study of pulmonary function in patients treated with paclitaxel and carboplatin.

Adverse effects of paclitaxel and carboplatin have been well described; however, pulmonary toxicity after patients receive this regimen has not been investigated extensively. To clarify this issue, 33 consecutive patients who were treated with paclitaxel and carboplatin underwent prospective evaluation of respiratory function, which included pulmonary symptoms, pulmonary function tests (PFTs), arterial blood gas levels, and radiographic studies. Assessment was performed before and after completion of chemotherapy in all patients. Patients with substantial declines in PFTs, defined as a decline > or = 20 percent in forced expiratory volume in 1 second (FEV1), total lung capacity (TLC), or diffusion capacity for carbon monoxide (DLCO), were reassessed 5 months later. After chemotherapy, there were no significant changes in forced vital capacity (FVC; 111%+/-21% of the predicted value before chemotherapy vs. 111+/-20% of the predicted value after chemotherapy), FEV1 (108%+/-24% of the predicted value before chemotherapy vs. 107%+/-22% of the predicted value after chemotherapy), FEV1/FVC ratio (79%+/-8% before chemotherapy vs. 78%+/-6% after chemotherapy), alveolar volume (VA; 95%+/-14% of the predicted value before chemotherapy vs. 96%+/-14% of the predicted value after chemotherapy), or TLC (96%+/-14% of the predicted value before chemotherapy vs. 97%+/-13% of the predicted value after chemotherapy). In contrast, there was a significant decline in DLCO (101%+/-20% of the predicted value before chemotherapy vs. 96+/-21% of the predicted value after chemotherapy; P < 0.05). Arterial blood gas levels did not change after treatment. No patient had decreased FEV1 or TLC levels by > or = 20%, whereas 4 of 33 patients (12%) exhibited a substantial decline (> or = 20%) in DLCO that persisted 5 months after treatment (DLCO at baseline, immediately after chemotherapy, and 5 months after the completion of chemotherapy, respectively: 99%+/-36% of the predicted value vs. 75%+/-28% of the predicted value vs. 74%+/-31% of the predicted value; P < 0.05). None of the 33 patients developed respiratory symptoms or had radiologic signs suggestive of lung toxicity. Among the various risk factors examined, baseline DLCO and FEV1 levels were associated with changes in DLCO post-treatment. This prospective analysis showed that the combination of paclitaxel with carboplatin induced an isolated decrease in DLCO level in the absence of clinical or radiologic evidence of toxicity. Further studies are needed to clarify whether this reduction in DLCO is predictive of subsequent pulmonary impairment.

Obstructive pulmonary function defects among Taiwanese firebrick workers in a 2-year follow-up study.

The purpose of the study was to follow up an earlier observation of pulmonary function among workers employed in firebrick-manufacturing factories. A 2-year follow-up study of pulmonary function among 442 workers in 30 firebrick-manufacturing factories was designed. Excluding 79 workers with a history of other occupational dust exposure, changes in pulmonary function of 291 firebrick workers were compared with pulmonary function in 72 control subjects over a period of 2 years. Baseline pulmonary function values (i.e., forced expiratory volume in 1 second [FEV1]/forced vital capacity [FVC] and forced expiratory flow after 50% of vital capacity has been expelled [FEF50%] in smoking firebrick workers, and FEV1/FVC and FEF75% in nonsmoking firebrick workers) were significantly lower than those in the comparison group. The statistical method for repeated measurements was used for comparison of the difference between follow-up and baseline lung function. There was no significant difference in FVC and FEV1 changes between firebrick workers and those in the comparison group during the 2-year follow-up period. The decreases in FEV1/FVC, peak expiratory flow rate, maximal midexpiratory flow, and FEF50% in the firebrick workers were significantly greater than in the comparison group, after adjustment for smoking status. The FEV1, maximal midexpiratory flow, FEF50%, and FEF75% also showed a dose-response relationship with job titles. The decrement of pulmonary function in the 2-year follow-up period was the worst in burning work, followed by crushing and molding. The results show that workers in firebrick-manufacturing factories with exposure to silica-containing dusts may contract obstructive pulmonary function defects.

Extrinsic allergic alveolitis from a proteolytic enzyme

Subtilisins are proteolytic enzymes of bacterial origin found in detergents. They are high-molecular-weight antigens and have been implicated in allergic rhinitis and asthma. This report describes a case of extrinsic allergic alveolitis due to subtilisins in a liquid cleaner. Clinical, radiologic, and serologic information were used to make the diagnosis. A 53-year-old woman developed respiratory symptoms while working with a cleaner containing subtilisins. Her symptoms intensified in the work environment and improved away from work. A computed tomography scan demonstrated alveolar and interstitial infiltrates with subsequent scarring. A pulmonary function study revealed a restrictive pattern with diminished diffusion capacity. Bronchoalveolar lavage showed lymphocytosis and all cultures were negative. Precipitating antibodies to the enzyme were found in the patient's serum. Her symptoms improved once she changed her occupation. The combination of the patient's clinical history, physical, laboratory, and radiologic findings support the diagnosis of extrinsic allergic alveolitis from the enzyme contained in the cleaner.

Impairment Tutorial: Respiratory System: Fifth Edition Redefines Normal

Abstract The AMA Guides to the Evaluation of Permanent Impairment (AMA Guides), Fifth Edition, changes the definition of “normal” (ie, the process of differentiating between an individual whose lung function is “normal” as opposed to an individual with Class 2 respiratory impairment) because the definition has changed over time. For example, the AMA Guides, First Edition (1971), used from the VA-Army 1961 Cooperative Study to construct tables of “normal” or “predicted” values during spirometry. Regression equations were used to calculate the predicted forced vital capacity, forced expiratory volume in the first second, and mandatory minute ventilation for men and women, by age and height. The Second Edition (1984) used data from a pulmonary function study in 251 healthy white individuals who lived 1400 meters above sea level (Utah), more than 90% of whom were members of the Mormon church (a very narrow segment of the American population). The AMA Guides, Third and Fourth Editions, continued to rely on the study just cited and made a distinction between “normal” and “mildly impaired.” The AMA Guides, Fifth Edition, uses the four classes of respiratory impairment and the same whole person impairment ratings for each class, unchanged from the Fourth Edition. The Fifth Edition has reverted to using the 95% confidence interval to determine “normal,” so that the same individual who, under the Fourth Edition guidelines was up to 25% impaired, would become normal under the pulmonary impairment guides of the Fifth Edition.

Modern statistical techniques for the analysis of longitudinal data in biomedical research

Longitudinal study designs in biomedical research are motivated by the need or desire of a researcher to assess the change over time of an outcome and what risk factors may be associated with the outcome. The outcome is measured repeatedly over time for every individual in the study, and risk factors may be measured repeatedly over time or they may be static. For example, many clinical studies involving chronic obstructive pulmonary disease (COPD) use pulmonary function as a primary outcome and measure it repeatedly over time for each individual. There are many issues, both practical and theoretical, which make the analysis of longitudinal data complicated. Fortunately, advances in statistical theory and computer technology over the past two decades have made techniques for the analysis of longitudinal data more readily available for data analysts. The aim of this paper is to provide a discussion of the important features of longitudinal data and review two popular modern statistical techniques used in biomedical research for the analysis of longitudinal data: the general linear mixed model, and generalized estimating equations. Examples are provided, using the study of pulmonary function in cystic fibrosis research.

A long-term study of pulmonary function at low exposures to chlorine

A total of 44 employees (43 men and 1 woman) in the chlorine plant at Akzo Nobel, Skoghall, have been studied with regard to pulmonary lung and bronchial function. This investigation is a follow-up study and registers the differences between the results of the studies performed in 1983 and 1994. The group being studied has been compared with a control group consisting of 33 white-collar workers (32 men and 1 women). The length of exposure to the gas varies between 9 and 40 years, with an average of 23 years. The concentration of chlorine gas in the plant has, as a rule, been less than 0.5 ppm. Pulmonary function has been registered with a spirometer, from which VC and FEV1.0 have been measured. The age of the group being studied is between 30 and 64 years and that of the control group is between 32 and 63 years.

Selection Effects on an Estimation of Long-Term Changes in Pulmonary Function

To reveal the association of initial pulmonary function level with subsequent mortality and participation in a follow-up reexamination, a prospective cohort study was performed. Female residents in a volcanic area of southern Kyushu, Japan, were followed up for their vital status and the pulmonary function 15 years after they received the first pulmonary function test. A cohort of 512 Japanese female residents who were examined for pulmonary function as indicated by forced expiratory volume and forced expiratory volume in one second was measured in a baseline examination in 1980. After 15 years, 35 females were lost to follow-up. Of the remaining 477 females, 340 and 137 females provided good and poor levels of pulmonary function tests (PFT) at baseline, respectively. Mortality by 1995 in the poor PFT group was significantly higher than that in the good PFT group (33.6% vs 9.4%). The mortality differences were still highly significant when the 35 lost cases were included as all alive. Among the 399 survivors, the nonparticipation rate in the reexamination in 1995 was significantly higher in the poor PFT group than that in the good PFT group (80.2% vs 69.5%). The results of the present study, a longitudinal study of pulmonary function, provide evidence of selection effects due to death or failure to participate in a subsequent reexamination.

The study of pulmonary function in patients with cerebrovascular diseas

The study of pulmonary function in patients with cerebrovascular diseas

Assessment of Cardiac and Pulmonary Function in Adult Patients with Hodgkin's Disease Treated with ABVD or MOPP/ABVD Plus Adjuvant Low-Dose Mediastinal Irradiation

We evaluated the long-term effects of combined modality therapy (CMT) with adria-mycin, bleomycin, vinblastine, dacurbazine (ABVD) or mechlorethamine, vincristine, prednisone, procarbazine (MOPP)/ABVD plus adjuvant low-dose (<30 Gy) involved-field radiation therapy (LDRT) on cardiac and pulmonary functions in adult patients with Hodgkin 's disease (HD). Adjuvant LDRT (mean dose, 2340 cGy) to the mediastinum was administered to 24 patients after chemotherapy with MOPP/ ABVD (n = 10) and ABVD (n = 14). The mean doses of doxorubicin and bleomycin were 233 mg/m2 and 92 IU/m2, respectively. Cardiac and pulmonary function tests were performed in all patients and, when available, were compared with pretreatment studies. After a median follow-up of 6.3 years, none of the patients had cardiac or pulmonary symptoms. A 4.7% overall decrease in left ventricular ejection fraction (LVEF) was observed (p = 0.03), but only one patient had a mildly decreased LVEF (47%). Diastolic function, LVEF, and left ventricular volume remained within the normal range in the other 23 patients. Mild pulmonary function study abnormalities occurred in 8 of 24 patients, 6 of whom were cigarette smokers. There were no significant changes in total lung capacity and forced vital capacity (FVC) values, but there was a 3% overall decrease in FEV1/FVC ratio (p = 0.05). In adult patients with HD, adjuvant LDRT after chemotherapy with ABVD or MOPP/ABVD did not result in a significant incidence of permanent pulmonary or cardiac toxicity after more than 6.3 years of median follow-up. Further studies are warranted to fully evaluate the impact of such therapy on cardiopulmonary function.

Pulmonary function in children with atrial septal defect before and after heart surgery

ObjectiveTo test the effect of heart disease and heart surgery on lung function.DesignA pulmonary function study of children undergoing surgery for atrial septal defect (ASD).SettingsUniversity hospital.Patients26 children tested before surgery...

Automatic calculation of total lung capacity from automatically traced lung boundaries in postero-anterior and lateral digital chest radiographs

Total lung capacity (TLC) is a very important parameter in the study of pulmonary function. In the pulmonary function laboratory, it is normally obtained using plethysmography or helium dilution techniques. Several authors have developed methods of calculating the TLC using postero-anterior (PA) and lateral chest radiographs. These methods have not been often used in clinical practice. In the present work, we have developed and automated computer-based method for the calculation of TLC, by determining the pulmonary contours from digital PA and lateral radiographs of the thorax. The automatic tracing of the pulmonary borders is carried out using: (1) a group of reference lines is determined in each radiograph; (2) a family of rectangular regions of interest (ROIs) defined, which include the pulmonary borders, and in each of them the pulmonary border is identified using edge enhancement and thresholding techniques; (3) removing outlaying points from the preliminary boundary set; and (4) the pulmonary border is corrected and completed by means of interpolation, extrapolation, and arc fitting. The TLC is calculated using a computerized form of the radiographic ellipses method of Barnhard. The pulmonary borders were automatically traced in a total of 65 normal radiographs (65 PA and 65 lateral views of the same patients). Three radiologists carried out a subjective evaluation of the automatic tracing of the pulmonary borders, with a finding of no error or only one minor error in 67.7% of the PA evaluations, and in 75.9% of the laterals. Comparing the automatically traced borders with borders traced manually by an expert radiologists, we obtained a precision of 0.990 +/- 0.001 for the PA view, and 0.985 +/- 0.002 for the lateral. The values of TLC obtained by the automatic calculation described here showed a high correlation (r = 0.98) with those obtained by applying the manual Barnhard method.